Michael F. Mahoney, Chairman, President, and CEO of Boston Scientific Corp. (BSX), acquired 186,240 shares of the company's stock on August 3, 2026. The transaction, valued at approximately $9.00 million, was executed at an average price of $48.33 per share.
This significant purchase by a top executive is generally viewed as a strong indicator of confidence in Boston Scientific's future prospects. The purchase comes amid other recent insider buying activity within the company, including acquisitions by David C. Habiger and Edward J. Ludwig.
The consistent buying from company insiders may signal a positive outlook from those with the most intimate knowledge of Boston Scientific's operations and strategic direction.